Use of Human chorionic gonadotropin (hCG) associated to a Cyclodextrin, sublingual oral or Intramuscular Injection for the treatment of various clinical manifestations and Laboratory of polycystic ovaries (PCO)

摘要

Medicine for the treatment of patients with different clinical manifestations and Laboratory of polycystic ovary.In patients with polycystic ovaries (PCO), the use of Human chorionic gonadotropin sublingually associated to a Cyclodextrin - oral or Intramuscular Injection (without Linking Cyclodextrin), following a Protocol allows simultaneous Monitoring and control Mind: irregular or absent menstrual periods, sporadic,Hirsutism: excessive growth of body and facial hair, including the chest, stomach and back or Oily Skin, acne, increased size and / or ovaries of polycystic, Infertility, overweight or obesity, especially around the waist and abdomen (Central Obesity), diabetes type 2 or insulin resistance, elevated cholesterol levels, High Blood Pressure,Elevated levels of Blood coagulation factors.Claim 1: Use of Human chorionic gonadotropin (hCG) associated to a Cyclodextrin, sublingual oral or Intramuscular Injection for the treatment of different clinical manifestations and Laboratory of polycystic ovary (PCO), characterized by the Administration Patient Under Medical supervision.Human chorionic gonadotropin (hCG) associated to a Cyclodextrin sublingually - oral or Intramuscular Injection, Daily doses (depending on Aggravating factors) that Fit between 300 to 600 International units Daily (oral), associated to a cyclodextrinWithholding gonadotrophin solution for 1 - 2 minutes in the oral cavity to facilitate its Absorption from the buccal mucosa, then eating), or 100 to 300 IU Injection of Human chorionic Gonadotrophin (hCG), during the treatment.